Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19
개별화 항생제 치료를 위한 프로칼시토닌: COVID-19에 초점을 맞춘 업데이트
Review
[키워드] antibiotic
Antibiotics
antimicrobial
antimicrobial resistance
Antimicrobial stewardship
Antimicrobial therapy
available data
Bacterial infection
benefit
Biomarker
Biomarkers
can be used
Care
Clinical data
clinical outcomes
clinical setting
coronavirus disease
Coronavirus disease 2019
COVID-19
determine
Diseases
Evidence
Health Organization
heterogeneous
implication
IMPROVE
key consideration
leads
limit
Patient
patients with COVID-19
PCT
Probability
procalcitonin
prognostic
protocols
provide
randomized trials
reducing
reductions
reductions in
respiratory
respiratory infection
respiratory infections
respiratory tract infection
Respiratory tract infections
Sepsis
severity
shown
Still
therapy
Trial
trials
use of antibiotics
Viral
World Health Organization
[DOI] 10.1080/10408363.2021.1975637 PMC 바로가기 [Article Type] Review
[DOI] 10.1080/10408363.2021.1975637 PMC 바로가기 [Article Type] Review